Literature DB >> 35776137

Spondyloepimetaphyseal dysplasia-Maroteaux type due to dominant TRPV4 mutation: expanding the phenotype with a case report.

Ceren Yılmaz Uzman1, Tufan Çankaya2, Handan Güleryüz3, Ayfer Ülgenalp4,2, Özlem Giray Bozkaya4.   

Abstract

INTRODUCTION: Dominant pathogenic mutations in the TRPV4 gene give rise to a wide spectrum of abnormal phenotypes, including bone dysplasia as well as spinal muscular atrophy and hereditary motor and sensory neuropathy. Spondyloepimetaphyseal dysplasias (SEMDs) are autosomal dominant skeletal dysplasias characterized by mild epiphyseal dysplasia, flared metaphyses, prominent joints, spondyler dysplasia, and brachydactyly with various carpal, metacarpal, and finger malformations. CASE
PRESENTATION: We present a boy who has the clinical and radiological signs of SEMD-M with a dominant TRPV4 mutation. He also has some striking findings that have not been seen in these patients before, and they may be able to provide assistance to medical professionals in the process of diagnosis.These include a shorter distance between his lumbar vertebrae, congenital contractures, and an arachnoid cyst.
© 2022. The Author(s), under exclusive licence to International Skeletal Society (ISS).

Entities:  

Keywords:  Skeletal dysplasia; Spondyloepimetaphyseal dysplasia; TRPV4

Year:  2022        PMID: 35776137     DOI: 10.1007/s00256-022-04105-6

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  11 in total

1.  Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio syndrome type 2), and parastremmatic dysplasia are caused by TRPV4 mutations.

Authors:  Gen Nishimura; Jin Dai; Ekkehart Lausch; Sheila Unger; André Megarbané; Hiroshi Kitoh; Ok Hwa Kim; Tae-Joon Cho; Francesca Bedeschi; Francesco Benedicenti; Roberto Mendoza-Londono; Margherita Silengo; Maren Schmidt-Rimpler; Jurgen Spranger; Bernhard Zabel; Shiro Ikegawa; Andrea Superti-Furga
Journal:  Am J Med Genet A       Date:  2010-06       Impact factor: 2.802

2.  Next-generation sequencing identifies TRPV4-related skeletal dysplasia in a boy with progressive bowlegs.

Authors:  Rai-Hseng Hsu; Wuh-Liang Hwu; Ming Chen; I-Fang Chung; Steven Shinn-Forng Peng; Chen-Yang Chen; Wei-Chung Cheng; Yin-Hsiu Chien; Ni-Chung Lee
Journal:  Pediatr Neonatol       Date:  2018-04-13       Impact factor: 2.083

3.  Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes.

Authors:  Lindsay C Burrage; John J Reynolds; Nissan Vida Baratang; Jennifer B Phillips; Jeremy Wegner; Ashley McFarquhar; Martin R Higgs; Audrey E Christiansen; Denise G Lanza; John R Seavitt; Mahim Jain; Xiaohui Li; David A Parry; Vandana Raman; David Chitayat; Ivan K Chinn; Alison A Bertuch; Lefkothea Karaviti; Alan E Schlesinger; Dawn Earl; Michael Bamshad; Ravi Savarirayan; Harsha Doddapaneni; Donna Muzny; Shalini N Jhangiani; Christine M Eng; Richard A Gibbs; Weimin Bi; Lisa Emrick; Jill A Rosenfeld; John Postlethwait; Monte Westerfield; Mary E Dickinson; Arthur L Beaudet; Emmanuelle Ranza; Celine Huber; Valérie Cormier-Daire; Wei Shen; Rong Mao; Jason D Heaney; Jordan S Orange; Débora Bertola; Guilherme L Yamamoto; Wagner A R Baratela; Merlin G Butler; Asim Ali; Mehdi Adeli; Daniel H Cohn; Deborah Krakow; Andrew P Jackson; Melissa Lees; Amaka C Offiah; Colleen M Carlston; John C Carey; Grant S Stewart; Carlos A Bacino; Philippe M Campeau; Brendan Lee
Journal:  Am J Hum Genet       Date:  2019-02-14       Impact factor: 11.025

4.  Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia.

Authors:  Natalia Camacho; Deborah Krakow; Sharlin Johnykutty; Philip J Katzman; Samuel Pepkowitz; Joris Vriens; Bernd Nilius; Brendan F Boyce; Daniel H Cohn
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

5.  Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations.

Authors:  Holly A Leddy; Amy L McNulty; Suk Hee Lee; Nicole E Rothfusz; Bernd Gloss; Margaret L Kirby; Mary R Hutson; Daniel H Cohn; Farshid Guilak; Wolfgang Liedtke
Journal:  FASEB J       Date:  2014-02-27       Impact factor: 5.191

6.  Spondyloepiphyseal dysplasia Maroteaux type: report of three patients from two families and exclusion of type II collagen defects.

Authors:  Gen Nishimura; Rika Kizu; Yoshimaro Kijima; Kiyoshi Sakai; Yoshiharu Kawaguchi; Tomoatsu Kimura; Isao Matsushita; Shuya Shirahama; Toshiyuki Ikeda; Shiro Ikegawa; Tomonobu Hasegawa
Journal:  Am J Med Genet A       Date:  2003-08-01       Impact factor: 2.802

7.  Novel microtubule polymerization inhibitor with potent antiproliferative and antitumor activity.

Authors:  Sonia Arora; Xin I Wang; Susan M Keenan; Christina Andaya; Qiang Zhang; Youyi Peng; William J Welsh
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

Review 8.  Spondyloepimetaphyseal dysplasia of Maroteaux (pseudo-Morquio type II syndrome): report of a new patient and review of the literature.

Authors:  André Mégarbané; Pierre Maroteaux; Catherine Caillaud; Martine Le Merrer
Journal:  Am J Med Genet A       Date:  2004-02-15       Impact factor: 2.802

Review 9.  TRPV4-associated skeletal dysplasias.

Authors:  Gen Nishimura; Ekkehart Lausch; Ravi Savarirayan; Masahiro Shiba; Juergen Spranger; Bernhard Zabel; Shiro Ikegawa; Andrea Superti-Furga; Sheila Unger
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-07-12       Impact factor: 3.908

10.  Nosology and classification of genetic skeletal disorders: 2019 revision.

Authors:  Geert R Mortier; Daniel H Cohn; Valerie Cormier-Daire; Christine Hall; Deborah Krakow; Stefan Mundlos; Gen Nishimura; Stephen Robertson; Luca Sangiorgi; Ravi Savarirayan; David Sillence; Andrea Superti-Furga; Sheila Unger; Matthew L Warman
Journal:  Am J Med Genet A       Date:  2019-10-21       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.